Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
27.8% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
25.2% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
5.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
XPO
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Automation And Regulatory Pressures Will Squeeze Operating Margins
Key Takeaways Rising automation, AI adoption, and new digital competitors threaten XPO's market share, efficiency, and ability to maintain pricing power. Sustainability mandates, labor shortages, and costly tech initiatives are likely to compress margins and impede future earnings growth.
View narrative
US$103.13
FV
15.4% overvalued
intrinsic discount
1.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
AngloGold Ashanti
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Obuasi And Nevada Challenges Will Test Efficiency But Unlock Opportunities
Key Takeaways Achieving cost competitiveness and production targets at key sites is crucial for future revenue growth, which may be at risk if improvements falter. High capital expenditures and sensitivity to gold price fluctuations pose risks to financial stability and projected earnings growth.
View narrative
US$38.00
FV
49.5% overvalued
intrinsic discount
1.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
United Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Patent Expirations And Biosimilar Pressures Will Diminish Value
Key Takeaways Heavy dependence on a few core drugs heightens risk from patent expirations, increasing vulnerability to revenue declines and competition from generics. Significant investments in novel therapies face technical and regulatory uncertainties, with potential delays and high costs threatening profitability and future earnings.
View narrative
US$295.00
FV
1.8% overvalued
intrinsic discount
1.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
UWM Holdings
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
High Rates And Margin Compression Will Hinder Mortgage Growth
Key Takeaways Reliance on aggressive pricing and traditional broker channels risks margin erosion and limits growth amid rising alternative financing models. Elevated operational complexity and regulatory scrutiny may increase costs and threaten profitability as technology and servicing investments expand.
View narrative
US$4.50
FV
0.9% overvalued
intrinsic discount
1.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
RVTY
Revvity
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Regulatory Shifts Will Pressure Diagnostics Yet Spur Measured Turnaround
Key Takeaways Regulatory shifts and market-specific declines threaten revenue growth and earnings recovery, despite innovation and expansion in high-growth segments. Heavy reliance on biopharma and diagnostics exposes Revvity to budget cuts and pricing pressures, undermining revenue stability and margin expansion.
View narrative
US$100.00
FV
14.2% undervalued
intrinsic discount
4.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
RB Global
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Digital Shifts And Decarbonization Will Erode Profit Margins
Key Takeaways Digital transformation and emerging competitors threaten RB Global's traditional auction model, pressuring fees, margins, and long-term revenue growth. Industry trends toward decarbonization and automation reduce demand for used equipment, shrinking the customer base and weakening earnings and profitability.
View narrative
US$77.23
FV
51.9% overvalued
intrinsic discount
8.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Gen Digital
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Open Source Cybersecurity Will Erode Margins Despite Subscription Recovery
Key Takeaways Free cybersecurity alternatives and enhanced device security features are reducing Gen Digital's core recurring revenue and eroding its product differentiation. Regulatory constraints and customer churn threaten personalization, product innovation, and long-term earnings growth.
View narrative
US$25.00
FV
23.1% overvalued
intrinsic discount
6.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Enphase Energy
AN
AnalystLowTarget
Consensus Narrative from 33 Analysts
Falling US Incentives And Rivalry Will Undermine Solar Markets
Key Takeaways Looming policy shifts and market saturation in core regions threaten Enphase's growth while limiting future residential solar revenue opportunities. Mounting competition and cost pressures from global rivals risk margin erosion and ongoing profitability challenges despite innovation efforts.
View narrative
US$27.00
FV
20.6% overvalued
intrinsic discount
-9.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
International Paper
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Rising Compliance Costs Will Limit Transformation Gains
Key Takeaways Ongoing shifts away from paper and regulatory pressures on packaging limit revenue growth, increase investment needs, and compress margins across the business. Heavy dependence on mature North American markets and lagging infrastructure investment weaken competitive positioning and threaten both earnings and dividend stability.
View narrative
US$42.10
FV
12.0% overvalued
intrinsic discount
7.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies